The Swedish government-owned food and drug manufacturer Procordia, and Sweden's car manufacturer, Volvo, reached an agreement allowing Volvo to become a majority shareholder in Procordia last week, but the Swedish government has rejected the proposed merger and was holding urgent talks with Volvo as the Marketletter went to press. Should the deal finally be allowed to go ahead, it would be Sweden's first privatization of a state-owned comp-any and one of Europe's biggest mergers.
The news of the agreement sent Procordia's shares plummeting, as the general feeling about the merger is that it would be good for Volvo, but not for Procordia. The latter's B-free shares dropped 6.6% in trading at the start of last week. Procordia, which controls Kabi Pharmacia, is offering nine of its shares for every four Volvo shares. Sweden's Prime Minister Carl Bildt said that the deal was "unacceptable" as it would mean too great a loss for the state.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze